# Risk: __Invasive individual testing__ (PBN__Risk_2367)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [individuals with symptoms or high-risk exposures](../Stakeholder/PBN__Stakeholder_1575)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskSource

* [wu_sars-cov-2_2020](../Article/PBN__Article_251)

## Property: has_RiskName

Decreased willingness to get tested, leading to underreporting of cases and limited knowledge of the true prevalence of the virus.

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [Yes](../RiskGBN/PBN__RiskGBN_1)

## Property: has_RiskTechnology

* [development of non-invasive testing techniques](../Technology/PBN__Technology_1972)
* [improvement of testing accuracy and reliability](../Technology/PBN__Technology_1973)

## Property: has_RiskOwner

* [healthcare systems](../Stakeholder/PBN__Stakeholder_193)
* [public health officials](../Stakeholder/PBN__Stakeholder_310)

## Property: has_RiskType

* [health](../RiskType/PBN__RiskType_4)

## Property: has_RiskDescription

Individual testing methods for COVID-19 require invasive procedures such as nasopharyngeal swabs, which can be uncomfortable and inconvenient.

## Property: has_RiskISO_Purpose

* [Well-being](../RiskISO/PBN__RiskISO_Impact_1)

## Property: has_RiskMitigation

* [Develop and promote non-invasive testing methods, such as saliva or wastewater-based surveillance, to increase testing uptake.](../RiskMitigation/PBN__RiskMitigation_3074)

